Superconducting resonator circuits at frequencies above the gap frequency

The frequency response of three superconductive niobium resonating circuits, formed by a Nb microstrip and a Nb tunnel junction, is measured and analyzed at frequencies above the superconducting gap frequency. The circuits are placed in a waveguide system and the frequency response is determined with a Fourier transform spectrometer. The calculated and measured resonance frequencies and bandwidths are in good agreement with the extreme anomalous limit of the Mattis–Bardeen theory on the anomalous skin effect in superconductors [D.C. Mattis and J. Bardeen, Phys. Rev. 111, 412 (1958)]. The observed loss is higher than predicted by this theory, in agreement with previous observations on Nb films. The use of other materials for striplines as tuning circuits for heterodyne superconducting tunnel junction mixers is analyzed

Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development

Objective: The aim of this study was to explore symptoms and symptom development during the earliest phases of rheumatoid arthritis (RA) in patients with seropositive arthralgia and patients newly diagnosed with RA

Anomalous spin-splitting of two-dimensional electrons in an AlAs Quantum Well

We measure the effective Lande g-factor of high-mobility two-dimensional electrons in a modulation-doped AlAs quantum well by tilting the sample in a magnetic field and monitoring the evolution of the magnetoresistance oscillations. The data reveal that |g| = 9.0, which is much enhanced with respect to the reported bulk value of 1.9. Surprisingly, in a large range of magnetic field and Landau level fillings, the value of the enhanced g-factor appears to be constant.Comment: 4 pages, 3 figure

The ac‐Josephson effect above the gap frequency

The rf‐power dependence of the ac‐Josephson steps is measured at 720 GHz, using small area Nb tunnel junctions. This frequency is well above the gap frequency of Nb. The junction is placed in a waveguide, and connected to a superconducting stripline, which effectively tunes out the junction capacitance and facilitates the coupling of the radiation to the junction. We observe three Josephson steps, and the first step crosses the zero current axis over a considerable range of rf‐power. This indicates the possible application of THz Josephson steps in voltage standards. The data are compared to the theory and we find clear evidence for the predicted intrinsic roll‐off of the Josephson current amplitude above the gap frequency

T cell subsets: An immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals

Objectives Anticitrullinated protein antibody (ACPA)+ individuals with non-specific musculoskeletal symptoms are at risk of inflammatory arthritis (IA). This study aims to demonstrate the predictive value of T cell subset quantification for progression towards IA and compare it with previously identified clinical predictors of progression. Methods 103 ACPA+ individuals without clinical synovitis were observed 3-monthly for 12 months and then as clinically indicated. The end point was the development of IA. Naïve, regulatory T cells (Treg) and inflammation related cells (IRCs) were quantified by flow cytometry. Areas under the ROC curve (AUC) were calculated. Adjusted logistic regressions and Cox proportional hazards models for time to progression to IA were constructed. Results Compared with healthy controls (age adjusted where appropriate), ACPA+ individuals demonstrated reduced naïve (22.1% of subjects) and Treg (35.8%) frequencies and elevated IRC (29.5%). Of the 103 subjects, 48(46.6%) progressed. Individually, T cell subsets were weakly predictive (AUC between 0.63 and 0.66), although the presence of 2 T cell abnormalities had high specificity. Three models were compared: model-1 used T cell subsets only, model-2 used previously published clinical parameters, model-3 combined clinical data and T cell data. Model-3 performed the best (AUC 0.79 (95% CI 0.70 to 0.89)) compared with model-1 (0.75 (0.65 to 0.86)) and particularly with model-2 (0.62 (0.54 to 0.76)) demonstrating the added value of T cell subsets. Time to progression differed significantly between high-risk, moderate-risk and low-risk groups from model-3 (p=0.001, median 15.4 months, 25.8 months and 63.4 months, respectively). Conclusions T cell subset dysregulation in ACPA+ individuals predates the onset of IA, predicts the risk and faster progression to IA, with added value over previously published clinical predictors of progression

Heterodyne mixing with Nb tunnel junctions above the gap frequency

The noise and gain of a heterodyne waveguide mixer employing Nb/Al2O3/Nb superconducting tunnel junctions with an on-chip integrated tuning element are measured and analyzed at 680-750 GHz and at 840 GHz. The lowest receiver noise temperatures are 400 K (double side band) at 720 GHz and 1500 K (3000 K including the beam splitter loss) at 840 GHz. We compare data of the pumped I-V curves with the quantum theory of mixing and demonstrate good agreement at frequencies well above the gap frequency

Another Avenue for Anatomy of Income Comparisons : Evidence from Hypothetical Choice Experiments

September 2010, Revised December 2010, Secondly Revised November 2011, Thirdly Revised May 2012, Fourthly Revised March 2013

Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a prototypical autoimmune arthritis affecting nearly 1% of the world population and is a significant cause of worldwide disability. Though prior studies have demonstrated the appearance of RA-related autoantibodies years before the onset of clinical RA, the pattern of immunologic events preceding the development of RA remains unclear. To characterize the evolution of the autoantibody response in the preclinical phase of RA, we used a novel multiplex autoantigen array to evaluate development of the anti-citrullinated protein antibodies (ACPA) and to determine if epitope spread correlates with rise in serum cytokines and imminent onset of clinical RA. To do so, we utilized a cohort of 81 patients with clinical RA for whom stored serum was available from 1–12 years prior to disease onset. We evaluated the accumulation of ACPA subtypes over time and correlated this accumulation with elevations in serum cytokines. We then used logistic regression to identify a profile of biomarkers which predicts the imminent onset of clinical RA (defined as within 2 years of testing). We observed a time-dependent expansion of ACPA specificity with the number of ACPA subtypes. At the earliest timepoints, we found autoantibodies targeting several innate immune ligands including citrullinated histones, fibrinogen, and biglycan, thus providing insights into the earliest autoantigen targets and potential mechanisms underlying the onset and development of autoimmunity in RA. Additionally, expansion of the ACPA response strongly predicted elevations in many inflammatory cytokines including TNF-α, IL-6, IL-12p70, and IFN-γ. Thus, we observe that the preclinical phase of RA is characterized by an accumulation of multiple autoantibody specificities reflecting the process of epitope spread. Epitope expansion is closely correlated with the appearance of preclinical inflammation, and we identify a biomarker profile including autoantibodies and cytokines which predicts the imminent onset of clinical arthritis